Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
基本信息
- 批准号:9285734
- 负责人:
- 金额:$ 20.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-03 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntiviral AgentsAntiviral TherapyBiologyBlood VesselsBone MarrowCapsidCell Culture SystemCell Culture TechniquesCell CycleCell DeathCell ProliferationCellsClone CellsComplementary DNAComplexComplex MixturesCoupledDNA DamageDNA biosynthesisDangerousnessDevelopmentDiseaseEncapsulatedEnvironmentEpithelial CellsEpitheliumEventEvolutionFoundationsGene ExpressionGene Expression ProfileGenesGenetic RecombinationGenetic TranscriptionGlobal ChangeHumanImmune systemImmunocompromised HostImmunosuppressionIndividualInfectionKidneyKnowledgeLaboratoriesLarge T AntigenLate PromotersMeasurementMeasuresMesenchymalMessenger RNAMicrofluidicsMonitorNatural ImmunityPaperPatternPeer ReviewPhysicsPolyomavirusPopulationPredispositionProcessProductionPrognostic MarkerProteinsProximal Kidney TubulesPublicationsPublishingRNAReactionResearchResolutionReverse TranscriptionSeriesSmall T AntigenSystemTherapeutic immunosuppressionTissuesTransplant RecipientsTransplantationTubular formationUrineViralViral GenesViral Tumor AntigensVirionVirusVirus DiseasesVirus ReplicationWorkbasecell typeexperimental studyinterestkidney cellkidney epithelial cellkidney infectionkidney vascular structurenext generation sequencingnovelpathogenprogramsresponsestemtranscriptomicsviral DNAvirology
项目摘要
Project Summary/Abstract
BKV is a ubiquitous polyomavirus that is carried by the majority of the human population as a
harmless lifelong persistent infection. BKV becomes a dangerous pathogen in
immunocompromised individuals, especially those undergoing kidney, bone marrow, or multi-
organ transplants. Under these conditions BKV can undergo a rampant infection of the kidney
with virus production occurring largely in the tubular epithelial cells. During productive infection
BKV undergoes a program of gene expression that results in the synthesis of three early
proteins called large T antigen (LT), small T antigen (ST), and truncT. These early proteins act
to alter cellular gene expression, capture cellular proteins needed for replication, and to initiate
viral DNA replication. Transcription from the viral late promoter is coordinated approximately
with the onset of viral DNA synthesis, and results in expression of the capsid genes and the
subsequent assembly of new virus particles. Nearly all our knowledge of BKV biology stems
from work in cell culture systems in which a homogeneous clonal cell population is infected with
a high multiplicity of virions. This allows events such as viral transcription and DNA replication,
and changes in cellular transcription to be monitored as infection proceeds. However, each of
these measurements is obtained from bulk culture and thus represents an average of the events
occurring in individual cells. Furthermore, BKV infections of humans occur in complex tissues,
such as the kidney, that consist of multiple cell types in close proximity. There is little knowledge
as to how viral infection is influenced by mesenchymal or other cell types that are adjacent to
infected cells, or of how infected cells influence the biology of their neighbors. In this application
we will develop single-cell transcriptomics coupled with high-throughput droplet microfluidics to
address these important questions. The patterns of viral and cellular transcription in individual
human kidney proximal tubule epithelial cells infected with BKV will be measured by
encapsulating individual cells in microdroplets and extracting RNA, with the droplets serving as
reaction vessels. The RNA isolated from each cell will be barcoded such that pooled infected
cell populations can be subjected to next generation sequencing (NGS) in bulk. Transcription
patterns from individual cells can then be extracted computationally by decoding the barcodes.
We will also perform this experiment using infected kidney epithelial cells mixed with uninfected
vascular cells. This will allow the coordinate examination of viral and cellular gene expression in
mixed cell populations. The successful execution of this research strategy will lead to a novel
platform that is broadly applicable to many types of viruses.
项目总结/摘要
BKV是一种普遍存在的多瘤病毒,由大多数人群携带,
无害的终身持续感染。BKV成为一种危险的病原体
免疫功能低下的个体,特别是那些经历肾脏、骨髓或多器官移植的个体,
器官移植在这些条件下,BKV可以进行猖獗的肾脏感染
病毒的产生主要发生在肾小管上皮细胞中。在生产性感染期间
BKV经历了一个基因表达程序,导致三个早期的合成,
称为大T抗原(LT)、小T抗原(ST)和truncT的蛋白质。这些早期蛋白质
改变细胞基因表达,捕获复制所需的细胞蛋白,并启动
病毒DNA复制从病毒晚期启动子的转录大约是协调的
与病毒DNA合成的开始,并导致表达衣壳基因和
新病毒粒子的后续组装。我们对BKV生物学的所有了解几乎都源于
来自细胞培养系统中的工作,其中同质克隆细胞群被感染
病毒粒子的高度多样性。这使得病毒转录和DNA复制等事件,
并随着感染的进行监测细胞转录的变化。但每
这些测量值是从大量培养物中获得的
发生在单个细胞中。此外,人类的BKV感染发生在复杂的组织中,
例如肾脏,由多种细胞类型紧密相连组成。知识很少
至于病毒感染是如何受到邻近的间充质或其他细胞类型的影响,
受感染的细胞,或受感染的细胞如何影响其邻居的生物学。本申请中
我们将开发单细胞转录组学与高通量液滴微流控技术相结合,
解决这些重要问题。个体中病毒和细胞转录的模式
用BKV感染的人肾近端小管上皮细胞将通过
将单个细胞包封在微滴中并提取RNA,微滴用作
反应容器从每个细胞分离的RNA将被条形码化,使得合并的感染的RNA将被标记。
细胞群可进行批量下一代测序(NGS)。转录
然后通过解码条形码可以计算地提取来自单个细胞的模式。
我们还将使用感染的肾脏上皮细胞与未感染的细胞混合进行这项实验。
血管细胞这将允许对病毒和细胞基因表达的协调检查,
混合细胞群。这一研究策略的成功执行将导致一部小说
该平台广泛适用于许多类型的病毒。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES M PIPAS其他文献
JAMES M PIPAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES M PIPAS', 18)}}的其他基金
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10401454 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Analysis of cellular factors limiting productive JC virus infections
限制生产性 JC 病毒感染的细胞因素分析
- 批准号:
10312804 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10030247 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10196991 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10621762 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Regulation of cellular functions by two human Polyomaviruses
两种人类多瘤病毒对细胞功能的调节
- 批准号:
9088664 - 财政年份:2016
- 资助金额:
$ 20.27万 - 项目类别:
Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
- 批准号:
9167182 - 财政年份:2016
- 资助金额:
$ 20.27万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8849838 - 财政年份:2014
- 资助金额:
$ 20.27万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8768850 - 财政年份:2014
- 资助金额:
$ 20.27万 - 项目类别:
Searching Environmental Metagenomes for Novel Infectious Cancer Agents (PQ12)
寻找环境宏基因组寻找新型传染性癌症病原体(PQ12)
- 批准号:
8382024 - 财政年份:2012
- 资助金额:
$ 20.27万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别: